Trial intelligence / Profile preview

Phase II double-blind vehicle-controlled study of SRD441 ointment in atopic dermatitis

2008-007323-64Phase 2Completed

Sponsor
Serentis
Start
Dec 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing SRD441 ointment with Vehicle ointment (2 arms). Primary endpoint: Investigator’s Global Assessment (IGA) of atopic dermatitis signs at Day 21. Started Dec 2008; status: completed.

02

Drugs

SRD-441
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on 2008-007323-64.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-007323-64.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call